Appearance of Early and Late Components of Epstein–Barr Virus-Associated Membrane Antigen in Daudi Cells Superinfected with P3HR-1 Virus

References

1. Dölken G., Klein G. 1976; Expression of Epstein–Barr virus-associated membrane antigen in Raji cells superinfected with two different virus strains. Virology 70:210–213
   [Google Scholar]
2. Ernberg I., Klein G., Kourilsky F. M., Silvestre D. 1974; Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein–Barr virus. I. Immunofluorescence. Journal of the National Cancer Institute 53:61–65
   [Google Scholar]
3. Gergely L., Klein G., Ernberg I. 1971; Appearance of Epstein–Barr virus-associated antigens in infected Raji cells. Virology 45:10–21
   [Google Scholar]
4. Henle G., Henle W. 1966; Immunofluorescence in cells derived from Burkitt’s lymphoma. Journal of Bacteriology 91:1248–1256
   [Google Scholar]
5. Henle W., Henle G., Zajac B. A., Pearson G., Waubke R., Scriba M. 1970; Differential reactivity of human sera with early antigens induced by Epstein–Barr virus. Science 169:188–190
   [Google Scholar]
6. Hinuma Y., Konn M., Yamaguchi J., Wudarski D. J., Blakeslee J. R. Jun, Grace J. T. Jun 1967; Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. Journal of Virology 1:1045–1051
   [Google Scholar]
7. Hinuma Y., Sairenji T., Ohota-Hatano R. 1970; Detection of antibody to a new antigen induced by Epstein–Barr virus in serums from patients with malignant lymphoid diseases. Proceedings of the Japan Academy 46:989–992
   [Google Scholar]
8. Ida S., Sairenji T., Hinuma Y. 1972; Antibodies to a new antigen induced by Epstein–Barr virus in patients with nasopharyngeal carcinoma, leukemia, malignant lymphoma, and in control groups. Gann 63:49–55
   [Google Scholar]
9. Klein G., Clifford P., Klein E, Stjernsward J. 1966; Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proceedings of the National Academy of Sciences of the United States of America 55:1628–1635
   [Google Scholar]
10. Klein G., Dombos L., Gothoskar B. 1972; Sensitivity of Epstein–Barr virus (EBV) producer and nonproducer human lymphoblastoid cell lines to superinfection with EB virus. International Journal of Cancer 10:44–57
    [Google Scholar]
11. Klein G., Pearson G., Henle G., Henle W., Goldstein G., Clifford P. 1969; Relation between Epstein–Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. III. Comparison of blocking of direct membrane immunofluorescence and anti-EBV reactivities of different sera. Journal of Experimental Medicine 129:697–705
    [Google Scholar]
12. Klein G., Pearson G., Nadkarni J. S., Nadkarni J. J., Klein E., Henle G., Henle W., Clifford P. 1968; Relation between Epstein–Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus. Journal of Experimental Medicine 128:1011–1020
    [Google Scholar]
13. Nadkarni J. S., Nadkarni J. J., Clifford P., Monolov G., Fenyo E. M., Klein E. 1969; Characteristics of new cell lines derived from Burkitt lymphomas. Cancer 23:64–79
    [Google Scholar]
14. Nagoya T., Hinuma Y. 1972; Production of infective Epstein–Barr virus in a Burkitt lymphoma cell line, P3HR-1. Gann 63:87–93
    [Google Scholar]
15. Nonoyama M., Pagano J. S. 1971; Detection of Epstein–Barr viral genome in non-productive cells. Nature New Biology 233:103–106
    [Google Scholar]
16. Pearson G. R., Henle G., Henle W. 1971; Production of antigens associated with Epstein–Barr virus in experimentally infected lymphoblastoid cell lines. Journal of the National Cancer Institute 46:1243–1250
    [Google Scholar]
17. Reedman B., Klein G. 1973; Cellular localization of an Epstein–Barr virus (EBV)-associated complementfixing antigen in producer and nonproducer lymphoblastoid cell lines. International Journal of Cancer 11:499–520
    [Google Scholar]
18. Sairenji T., Hinuma Y. 1973; Modes of Epstein–Barr virus-infection in human floating cell lines. Gann 64:583–590
    [Google Scholar]
19. Sairenji T., Hinuma Y. 1975; Ultraviolet inactivation of Epstein–Barr virus: Effect on synthesis of virus-associated antigens. International Journal of Cancer 16:1–6
    [Google Scholar]
20. Silvestre D., Ernberg I., Neauport-Sautes C., Kourilsky F. M., Klein G. 1974; Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein–Barr virus. II. Immunoelectron microscopy. Journal of the National Cancer Institute 53:67–74
    [Google Scholar]
21. Svedmyr A., Demissie A., Klein G., Clifford P. 1970; Antibody patterns in different human sera against intracellular and membrane-antigen complex associated with Epstein–Barr virus. Journal of the National Cancer Institute 44:595–610
    [Google Scholar]
22. Takahashi H., Hinuma Y. 1970; Nature of antigens of cultured Burkitt lymphoma cells, as revealed by membrane immunofluorescence. Gann 61:337–346
    [Google Scholar]
23. Thorley-Lawson D., Strominger J. L. 1976; Transformation of human lymphocytes by Epstein–Barr virus is inhibited by phosphonoacetic acid. Nature, London 263:332–334
    [Google Scholar]
24. Yajima Y., Nonoyama M. 1976; Mechanisms of infection with Epstein–Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells. Journal of Virology 19:187–194
    [Google Scholar]
25. Yajima Y., Tanaka A., Nonoyama M. 1976; Inhibition of productive replication of Epstein–Barr virus DNA by phosphonoacetic acid. Virology 71:352–354
    [Google Scholar]
26. Zur Hausen H., Henle W., Hummeler K., Diehl V., Henle G. 1967; Comparative study of cultured Burkitt tumor cells by immunofluorescence, autoradiography, and electron microscopy. Journal of Virology 1:830–837
    [Google Scholar]
27. Zur Hausen H., Schulte-Holthausen H. 1970; Presence of EB virus nucleic acid homology in a ‘virus-free, line of Burkitt tumor cells. Nature, London 227:245–248
    [Google Scholar]